Genotype-phenotype correlations in pediatric patients with myotonic dystrophy type 1
- Author:
Hyeong Jung KIM
1
;
Ji Hoon NA
;
Young Mock LEE
Author Information
- Publication Type:Original Article
- Keywords: Myotonic dystrophy type 1; Genotype; Phenotype; CTG repeat; Age of onset
- MeSH: Age of Onset; Cohort Studies; Deglutition Disorders; Genetic Association Studies; Genotype; Humans; Infant, Newborn; Intensive Care, Neonatal; Muscle Hypotonia; Myotonic Dystrophy; Myotonin-Protein Kinase; Parturition; Phenotype; Prognosis; Retrospective Studies; Ventilators, Mechanical
- From:Korean Journal of Pediatrics 2019;62(2):55-61
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: Myotonic dystrophy, also known as dystrophia myotonica (DM), is an autosomal dominant disorder with 2 genetically distinct forms. DM type 1 (DM1) is the more common form and is caused by abnormal expansion of cytosine/thymine/guanine (CTG) repeats in the DM protein kinase (DMPK) gene. Our study aimed to determine whether the age of onset is correlated with CTG repeat length in a population of pediatric patients with DM1. METHODS: We retrospectively identified 30 pediatric patients with DM1 that underwent DMPK testing, of which the clinical data of 17 was sufficient. The cohort was divided into 2 subgroups based on the clinical phenotype (congenital-onset vs. late-onset) and number of CTG repeats ( < 1,000 vs. ≥1,000). RESULTS: We found no significant difference between the age of onset and CTG repeat length in our pediatric patient population. Based on clinical subgrouping, we found that the congenital-onset subgroup was statistically different with respect to several variables, including prematurity, rate of admission to neonatal intensive care unit, need for respiratory support at birth, hypotonia, dysphagia, ventilator dependence, and functional status on last visit, compared to the late-onset subgroup. Based on genetic subgrouping, we found a single variable (poor feeding in neonate) that was significantly different in the large CTG subgroup than that in the small CTG subgroup. CONCLUSION: Clinical variables exhibiting statistically significant differences between the subgroups should be focused on prognosis and designing tailored management approaches for the patients; our findings will contribute to achieve this important goal for treating patients with DM1.
